MREO Financial Facts
Total sales: 99.23KNET (LOSS): -169.29K
See Full Income Statement
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT): 462.05K
Total stockholder's (deficit): -1.23M
See Full Balance Sheet
Mereo BioPharma Group plc (MREO) Earnings
|
Expand Research on MREO
| Next EPS Date | 11/18/26 *Est. | EPS Growth Rate | +50.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -75.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +0.6% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/11/26  |
Q226 | -$0.01 | -$0.01 | $0.00 | N/A | $2.33M | N/A |  | | Details | |
| 5/12/26 |
Q126 | -$0.01 | -$0.01 | $0.00 | N/A | $17.5M | N/A | | | Details | |
| 4/1/26 |
Q126 | N/A | -$0.01 | N/A | N/A | $30M | N/A | N/A | N/A | ||
| 11/18/25 |
Q325 | N/A | $0.01 | N/A | N/A | $17.5M | N/A | N/A | N/A | ||
| 8/12/25 | Q225 | -$0.02 | $0.00 | -$0.02 | N/A | N/A | N/A | | | Details | |
| 5/13/25 |
Q125 | -$0.02 | $0.01 | -$0.03 | N/A | $26.88M | N/A | | | Details | |
| 3/26/25 |
Q424 | N/A | -$0.01 | N/A | N/A | $36.25M | N/A | N/A | N/A | ||
| 9/17/24 | Q324 | N/A | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A |
